A. Ostrem (Oslo, Norway), T. van der Molen (Groningen, Netherlands), J. Sousa (Braga, Portugal), R. Jones (Plymouth, United Kingdom)
LATE-BREAKING ABSTRACT: The certification of allergy-, asthma- and COPD-clinics in primary care in Southern Sweden B. Lagorstrand, L. Bjermer, M. Kåregård, A. Tunsäter, K. Romberg (Lund, Malmö, Höllviken, Sweden)
| |
Cross sectional analysis of COPD care by specialists and general practitioners – National survey Y. Ivanov, A. Torossian, D. Kostadinov, D. Osmanliev, D. Petkova, K. Kostov, O. Georgiev, V. Hodzhev, N. Kyuchukov, N. Yanev, P. Hristova (Pleven, Plovdiv, Sofia, Varna, Bulgaria)
| |
Hospital care patterns in the management of acute exacerbated chronic obstructive pulmonary disease - A retrospective analysis from Zurich, Switzerland D. Franzen, F. Graf, S. Wieser, S. Beyer, T. Hess, N. Badertscher, K. Della Lana, M. Kohler, O. Senn, C. Steurer-Stey (Zurich, Winterthur, Switzerland)
| |
Effect of cardiac comorbidities on hospital mortality and duration of hospitalization in hospitalized COPD exacerbations Y. Havlucu, E. Kaya, G. Salanturoglu, A. Yorgancioglu (Manisa, Turkey)
| |
Impact of chronic obstructive pulmonary disease (COPD) and patients' absence from work in Greece - the GOLDEN II study E. Mitsiki, M. Toumbis, M. Alhanatis, N. Rovina, M. Kakoura, V. Filaditaki, G. Tsoukalas, E. Fouka, D. Lagonidis, K. Gourgoulianis (Athens, Thessaloniki, Giannitsa, Larisa, Greece)
| |
Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort N. Abu Hussein, E. Sonderer, P. O. Bridevaux, P. Chhajed, J. W. Fitting, T. Geiser, L. Joos Zellweger, M. Kohler, S. Maier, D. Miedinger, S. Schafroth Tötök, R. Thurnheer, M. Tamm, J. D. Leuppi (Liestal, Basel, Geneva, Lausanne, Berne, Zurich, Muensterlingen, Switzerland)
| |
Assessment of patients with COPD according to previous and new GOLD: Which stage in which group? G. Karadeniz, S. Ozkan, O. F. Erer, F. Sever, H. Cengiz (Izmir, Turkey)
| |
COPD: Pulmonary damage beyond FEV1 S. Denker, A. Rudolphus, A. Roos, J. In 't Veen (Rotterdam, Netherlands)
| |
Patients' experiences immediately prior to admission for an acute exacerbation of chronic obstructive pulmonary Disease (AECOPD) C. Spencer, D. Dimov (Leeds, United Kingdom)
| |
Diaphragmatic muscle ultrasound in COPD patients C. Oancea, O. Fira-Mladinescu, A. Crisan, E. Tudorache, A. Somesan, N. Bertici, V. Tudorache (Timisoara, Baia Mare, Romania)
| |
Lung function and associations with multiple dimensions of dental health C. Henke, R. Jörres, S. Budweiser (Mühldorf, Munich, Rosenheim, Germany)
| |
Effectiveness of indacaterol with or without tiotropium in patients with moderate or severe chronic obstructive pulmonary disease (COPD) - the GOLDEN II study M. Toumbis, E. Mitsiki, D. Papapetrou, K. Marosis, V. Gkoumas, D. Spyratos, K. Kallergis, P. Demertzis, D. Zorpidou, S. Michaelidis, K. Gourgoulianis (Athens, Thessaloniki, Rethymno, Larisa, Greece)
| |
Vitamin D deficiency on lung function and emphysema in smoker Y. J. Jung, B. Y. Lee, S. D. Lee, Y. M. Oh (Seoul, Republic Of Korea)
| |
Comparison of the effects of two rehabilitation methods in COPD subjects B. Janackov, Z. Stojanovski, J. Minov (Skopje, Fyrom)
| |
Long-term treatment with azithromycin is not associated with heart rhythm or QT interval disorders in children M. Moreno, D. Espadas, S. Castillo, C. Moreno, E. Martinez, A. Escribano (Valencia, Spain)
| |
No differences? Aerosol characteristics of 9 jet nebulisers tested in vitro H. Walz-Jung, W. Kamin, I. Krämer (Mainz, Hamm, Germany)
| |
Family physicians step therapy up in symptomatic COPD patients differently than respiratory specialists A. Kaplan, M. A. Cyr (Toronto, Montreal, Canada)
| |
GP survey on how to incorporate LABA/LAMA fixed dose combinations (FDC) in their COPD patients A. Kaplan, D. Hill, M. A. Cyr (Toronto, Castlemore, Montreal, Canada)
| |
COPD exacerbations and hospitalizations in COPDs with hypertension Z. Stojanovski, A. Peltekovski, J. Minov (Skopje, Fyrom)
| |